The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) and Epican Medicinals, announced this week that the companies have successfully opened their first legal cannabis retail store in the city of Kingston, Jamaica.
This retail store will be the companies flagship retail store and is expected to provides them with revenue from the sale of premium Jamaican grown organic cannabis. The retail store is 4,000 sq. ft. and is the first of a series of retail stores to be opened by TGOD and Epican in 2018.
TGOD currently owns 49.18% of Epicans operations in Jamaica. The two companies currently have established licenses involved in cannabis cultivation, extraction, manufacturing, and retail distribution in the country. They have also recently started construction on a a 125,000 sq. ft. cultivation facility.
Csaba Reider, President of TGOD stated, “The Kingston dispensary is an important step in TGOD’s global strategy. Commercializing legalized, high-quality, organic medical cannabis to the market is proof of our commitment to portfolio companies and our ability to go beyond cash infusion. The Epican team are great business partners and we would like to thank all those involved who have made this day happen.”
You may be interested
Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio OregonEditor - November 27, 2018
Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…
Wayland Group Enters UK Cannabis Market with Theros Pharma AcquisitionEditor - November 26, 2018
Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…
GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical TrialsEditor - November 26, 2018
GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…